Carfilzomib Applicable To The Treatment Of Multiple Myeloma Patients

English Product Name: Kyprolis (Carfilzomib)

Chinese medicine name: card isazomil

Dosage specifications: sterile freeze-dried powder; 60mg

Manufacturer: United States Anjin


Carboviram KYPROLIS is a proteasome inhibitor that is suitable for use in the treatment of patients with multiple myeloma who have received at least two previous treatments including bortezomib and immunomodulatory drugs to confirm disease progression or 60 days after the last treatment is completed.

Dosage and Administration:

(1, 2, 8, 9, 15, and 16 days), followed by 12-day rest periods (days 17 to 28) for 2 to 10 minutes per week for 2 consecutive days.

(2) Recommended treatment 1 dose is 20 mg / m2 / day and if the tolerance increases the dose of the second course of treatment and the subsequent treatment dose to 27 mg / m2 / day.

(3) before and after hydration patients.

(4) Pretreatment with dexamethasone prior to all first course doses. In the first course of treatment, and if the infusion reaction occurs or occurs again.

(5) Administration according to toxicity. The

Contraindications: none

Save and store:

Unopened vials should be stored in the refrigerator (2 ° C to 8 ° C; 36 ° F to 46 ° F). Keep in the original packaging protected from light.

How to get Kyprolis:

According to the actual situation of patients through legal channels to help them quickly and easily obtain the prescription drugs.